Understanding viral entry mechanisms matters beyond infectious disease—it reveals how pathogens exploit fundamental cellular pathways that govern metabolism and health. This discovery that hepatitis A virus hijacks the same receptor cells use to import cholesterol could reshape both antiviral strategies and our understanding of metabolic vulnerabilities. The research demonstrates that the low-density lipoprotein receptor (LDLR), primarily known for cholesterol homeostasis, serves as the primary cellular entry point for nonenveloped hepatitis A virus. This finding resolves longstanding scientific debate about how this common foodborne pathogen infiltrates liver cells. Previous work incorrectly identified the phosphatidylserine receptor TIM1 as essential, but controlled experiments now show LDLR facilitates viral binding and internalization through its ligand-binding domain. This represents a significant advance in virology, revealing how a major human pathogen exploits a ubiquitous metabolic receptor. The implications extend beyond hepatitis A prevention. LDLR expression varies dramatically between individuals based on genetic polymorphisms, dietary patterns, and statin use—factors that could influence infection susceptibility. More broadly, this connects viral pathogenesis to cholesterol metabolism, suggesting that lipid-lowering interventions might inadvertently affect immune vulnerability. The finding also highlights a recurring theme in infectious disease: pathogens often commandeer essential cellular machinery rather than relying on specialized viral receptors. While this single study requires replication across diverse viral strains and cell types, it potentially opens new therapeutic avenues targeting the LDLR-virus interaction while advancing our understanding of how metabolic health intersects with infectious disease resistance.